| FuGENE 6 Transfection Reagent: the gentle power. | |
| | |
MedLine Citation:
|
PMID: 15121164 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
FuGENE 6 Transfection Reagent has been commercially available since 1997. Since that time, its popularity has increased due to its ease of use, minimal to no cytotoxicity, and the high level of transfection in many different cell lines. FuGENE 6 Transfection Reagent is gentle on the cells. Adherent cells can be trypsinized and transfected by the DNA:FuGENE 6 reagent complex prior to plating, making it a strong candidate for high throughput applications. Additionally, low cell numbers can be transfected in 96-well plates. As with most reagents, the complex formation step is critical and special handling is required because the reagent is supplied in 80% ethanol. For example, contact with plastic must be avoided as inhibitors of transfection can leach from some plastics. We investigated parameters that have been reported to affect the transfection efficiency including the use of common antibiotics, passage level of the cells, and length of time for complex formation. These parameters are often cell line dependent and can be optimized to increase transfection efficiency for a specific cell line. |
| | |
Authors:
|
Linda B Jacobsen; Susan A Calvin; Kim E Colvin; MaryJo Wright |
Related Documents
:
|
16961264 - Expression of recombinant baculovirus carrying schistosoma japonicum 26 ku gst in mamma... 19876724 - N1,n12-diacyl spermines: sar studies on non-viral lipopolyamine vectors for plasmid dna... 14647384 - Angiotensin-converting enzyme 2 is a functional receptor for the sars coronavirus. 15862464 - Hek293 cell line: a vehicle for the expression of recombinant proteins. 19994864 - 4-pyridylanilinothiazoles that selectively target von hippel-lindau deficient renal cel... 10792784 - Quantitative analysis of apoptotic cell death in granulomatous inflammation induced by ... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Methods (San Diego, Calif.) Volume: 33 ISSN: 1046-2023 ISO Abbreviation: Methods Publication Date: 2004 Jun |
Date Detail:
|
Created Date: 2004-05-03 Completed Date: 2004-12-21 Revised Date: 2006-05-01 |
Medline Journal Info:
|
Nlm Unique ID: 9426302 Medline TA: Methods Country: United States |
Other Details:
|
Languages: eng Pagination: 104-12 Citation Subset: IM |
Copyright Information:
|
Copyright 2003 Elsevier Inc. |
Affiliation:
|
Roche Applied Science, Roche Diagnostics Corporation, 9115 Hague Road, Indianapolis, IN 46250-0414, USA. linda.jacobsen@roche.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Anti-Bacterial Agents / pharmacology Cell Count Cell Line Humans Lac Operon / genetics Lipids / chemistry* Plasmids / genetics Transfection / methods* |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Bacterial Agents; 0/FuGene; 0/Lipids |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput a...
Next Document: Mouse embryonic stem cells efficiently lipofected with nuclear localization peptide result in a high...